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Abstract
Insulin stimulates the tyrosine kinase activity of its receptor, resulting
in the phosphorylation of its cytosolic substrate, insulin receptor
substrate 1 (IRS-1). IRS-1 is also a substrate for different peptides and
growth factors, and a transgenic mouse “knockout” for this protein
does not have normal growth. However, the role of IRS-1 in kidney
hypertrophy and/or hyperplasia was not investigated. In the present
study we investigated IRS-1 protein and tyrosine phosphorylation
levels in the remnant kidney after unilateral nephrectomy (UNX) in 6-
week-old male Wistar rats. After insulin stimulation the levels of
insulin receptor and IRS-1 tyrosine phosphorylation were reduced to
79 ± 5% (P<0.005) and 58 ± 6% (P<0.0001), respectively, of the
control (C) levels, in the remnant kidney. It is possible that a circulat-
ing factor and/or a local (paracrine) factor playing a role in kidney
growth can influence the early steps of insulin action in parallel. To
investigate the hypothesis of a circulating factor, we studied the early
steps of insulin action in liver and muscle of unilateral nephrecto-
mized rats. There was no change in pp185 tyrosine phosphorylation
levels in liver (C 100 ± 12% vs UNX 89 ± 9%, NS) and muscle (C 100
± 22% vs UNX 91 ± 17%, NS), and also there was no change in IRS-
1 phosphorylation levels in both tissues. These data demonstrate that
after unilateral nephrectomy there is a decrease in insulin-induced
insulin receptor and IRS-1 tyrosine phosphorylation levels in kidney
but not in liver and muscle. It will be of interest to investigate which
factors, probably paracrine ones, regulate these early steps of insulin
action in the contralateral kidney of unilaterally nephrectomized rats.
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One of the earliest cellular responses to
stimulation by insulin is the activation of
insulin receptor kinase and tyrosine phos-
phorylation of insulin receptor ß subunit and
pp185, a cytoplasmic phosphoprotein found
in most cells and tissues (1). A component of
the pp185 band was purified and cloned
from several sources (2,3). The cloned pro-
tein was called insulin receptor substrate 1
(IRS-1). This insulin receptor substrate is a
cytoplasmic protein that is rapidly phospho-
rylated at a specific tyrosine after insulin
stimulation and is important in mediating the
metabolic and growth-promoting effects of
this hormone. IRS-1 is also a substrate for
different peptides and growth factors (1,2,4,5)
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including IGF-1 and GH, and a transgenic
mouse “knockout” for this protein does not
have normal growth. IGF-1 and its receptor
have been involved in kidney compensatory
hypertrophy after unilateral nephrectomy
(UNX) or diabetes. However, the role of
IRS-1 in kidney hypertrophy and/or hyper-
plasia was not investigated. The first aim of
this study was to investigate IRS-1 protein
and tyrosine phosphorylation levels in the
remnant kidney after UNX.
Male Wistar rats (6 weeks old) under-
went unilateral left nephrectomy (the kid-
neys were trimmed of fat and capsule and the
adrenal glands were left intact), as described
previously (6), or sham operation, where a
flank incision was made and the left kidney
was manipulated, but not removed. The ani-
mals recovered and received food and water
ad libitum. After seven days, the rats were
anesthetized with sodium amobarbital (15
mg/kg body weight, intraperitoneally) and
used in experiments 10-15 min later, as soon
as anesthesia was confirmed by the loss of
pedal and corneal reflexes. The abdominal
cavity was opened, the vena cava exposed
and 0.5 ml of normal saline (0.9% NaCl)
containing or not 10 µM insulin was in-
jected. After 30 or 90 s, fragments of liver
and muscle, respectively, were removed,
minced coarsely and immediately homog-
enized in approximately 6 volumes of solu-
bilization buffer A using a Polytron PTA
20S generator (Brinkmann Instruments, mo-
del PT 10/35) operated at maximum speed
for 30 s in a water bath maintained at 100oC
as previously described (7-9). To investigate
IRS-1 phosphorylation in kidney, saline with
or without insulin was infused into the vena
cava and the remnant kidney was extracted
90 s later in the same way as described for
liver and muscle. Solubilization buffer A
contained 1% SDS, 50 mM HEPES, pH 7.4,
100 mM sodium pyrophosphate, 100 mM
sodium fluoride, 10 mM EDTA, and 10 mM
sodium vanadate. The homogenates were
then boiled for 10 min and cooled in an ice
bath for 40 min. In some experiments, kid-
ney, liver and muscle were excised and ho-
mogenized with a Polytron apparatus in 6
volumes of homogenization buffer B cooled
in an ice bath. The composition of buffer B
was the same as buffer A except that 1%
Triton X-100 replaced 1% SDS and 2 mM
PMSF and 0.1 mg/ml aprotinin were added.
Both extracts were centrifuged at 100,000 g
(55,000 rpm) at 4oC in a Beckman 70.1 Ti
rotor for 30 min to remove insoluble mate-
rial, and the resulting supernatant was used
for the experiments. The kidney, liver and
muscle homogenized in buffer B were used
for immunoprecipitation with anti-IRS-1
antibody and Protein A-Sepharose 6 MB.
The samples were treated with Laemmli
sample buffer (10) containing 100 mM DTT
and heated in a boiling water bath for 4 min.
For total extracts, similar size samples (150
µg of protein) were submitted do SDS/PAGE
(6.5% Tris/acrylamide) in a Bio-Rad minia-
ture slab gel apparatus (11). Electrotransfer
of proteins from the gel to nitrocellulose was
performed for 2 h at 100 V (constant) in the
Bio-Rad miniature transfer apparatus (Mini-
protean), as described by Towbin et al. (12)
but with 0.02% SDS added to the transfer
buffer to enhance the elution of high molec-
ular mass protein. Nonspecific protein bind-
ing to the nitrocellulose was reduced by pre-
incubating the filter overnight at 4oC in block-
ing buffer (3% BSA, 10 mM Tris, 150 mM
NaCl, and 0.02% Tween 20). The prestained
molecular mass standards used were myosin
(205 kDa), β-galactosidase (116 kDa), BSA
(80 kDa) and ovalbumin (49.5 kDa). The
nitrocellulose blot was incubated with anti-
phosphotyrosine antibody (1 µg/ml) for 4 h
at 22oC. The blots were subsequently incu-
bated with 2 µCi of 125I-Protein A (30 µCi/
µg) in 10 ml of blocking buffer for 1 h at
22oC and washed for 2 h. 125I-Protein A
bound to the antibodies was detected by
autoradiography using preflashed Kodak
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XAR film with Cronex Lightning Plus inten-
sifying screens at -70oC for 12-48 h. Band
intensities were quantified by densitometry
(Molecular Dynamics) of the developed au-
toradiogram.
In the present study we evaluated the
effect of UNX on insulin receptor and IRS-1
phosphorylation in the remnant kidney. There
was no change in insulin receptor protein
levels as determined by immunoblotting with
an antibody to the C-terminus of the insulin
receptor (data not shown). Following insulin
infusion into the vena cava, a phosphotyro-
sine band of 95 kDa, previously identified as
the insulin receptor ß subunit (1,13,14), ap-
peared and became prominently phospho-
rylated. The level of phosphorylation of this
band was reduced to 79 ± 5% (P<0.005) in
the remnant kidney. In addition to the 95-
kDa band seen after insulin injection, a broad
band migrating between 165 and 185 kDa
was also detectable (Figure 1A). This band is
known as pp185 and IRS-1 is one compo-
nent of this band (15). The phosphorylation
of pp185 was reduced to 58 ± 6% (P<0.0001)
in the remnant kidney. In order to character-
ize IRS-1 phosphorylation after insulin stim-
ulation, we immunoprecipitated kidney ex-
tracts with anti-IRS-1 antibody and immu-
noblotted these with anti-IRS-1 and anti-
phosphotyrosine antibody (Figure 1B). There
was no change in IRS-1 protein levels in the
remnant kidney. However, after insulin stim-
ulation IRS-1 tyrosine phosphorylation was
reduced to 41 ± 5% (P<0.0001) in the kidney
of UNX rats compared to the kidney of
control rats. The mechanism(s) responsible
for the reduction in insulin receptor and IRS-
1 tyrosine phosphorylation in the remnant
kidney after 7 days of UNX have not been
elucidated. The regulation of insulin recep-
tor and IRS-1 is under the control of differ-
ent situations such as fasting, obesity, hor-
mones and diabetes. We have previously
demonstrated that in other tissues the excess
of cortisol (16), glucagon (7), epinephrine
(9), and GH (17) and also hyperinsulinemia
(13) can modulate the early steps of insulin
action by inducing a reduction in insulin
receptor and IRS-1 phosphorylation. How-
ever, none of these hormones is in excess in
our animal model of kidney growth. It is
possible that a circulating factor and/or a
local (paracrine) factor that plays a role in
kidney growth can influence the early steps
of insulin action in parallel. If there is a
Figure 1 - A, Insulin receptor (IR) and pp185 tyrosine phosphorylation in remnant
kidney tissue after saline (-) or saline plus 10 µM insulin (+) in unilaterally
nephrectomized (UNX) rats, compared with controls. The tissue was extracted
as described in Methods and immunoblotting (Blot) of total tissue extracts was
performed with anti-phosphotyrosine antibody (PY) and 125I-Protein A. B, Effect
of unilateral nephrectomy on insulin receptor substrate 1 (IRS-1) in the rat
remnant kidney. Kidney extracts from controls and unilaterally nephrectomized
rats were immunoprecipitated (IP) with anti-IRS-1 antibody (α IRS-1) and then
immunoblotted with anti-phosphotyrosine antibody.
A - Blot: PY
UNX Control






B - IP: α IRS-1
Blot: PY
UNXControl
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Figure 2 - Effect of unilat-
eral nephrectomy (UNX) on
insulin receptor substrate 1
(IRS-1) in the rat liver and
muscle. The liver extracts
from controls and unilater-
ally nephrectomized rats
were immunoprecipitated
(IP) with anti-IRS-1 antibody
(α IRS-1) and then immuno-
blotted (Blot) with anti-
phosphotyrosine antibody
(PY) (A). The same proce-
dure was applied to muscle
(B).
unilateral nephrectomized rats. The experi-
ments were performed as described above,
except that we infused insulin into the portal
vein, and extracted liver and muscle as de-
scribed above. The results of total tissue
extracts showed that in liver there was no
change in pp185 phosphorylation levels (C
100 ± 12% vs UNX 89 ± 9%, NS). In accor-
dance, after immunoprecipitation with anti-
IRS-1 antibody and blotting with anti-phos-
photyrosine antibody there was also no
change in IRS-1 tyrosine phosphorylation in
the liver of UNX rats (Figure 2A). In muscle
the results were very similar with no change
in insulin-induced pp185 phosphorylation
(C 100 ± 22% vs UNX 91 ± 17%, NS) and
also in IRS-1 tyrosine phosphorylation (Fig-
ure 2B) in UNX rats.
In summary, the data demonstrated that
after UNX there was a decrease in insulin-
induced insulin receptor and IRS-1 tyrosine
phosphorylation levels in the remnant kid-
ney but not in liver and muscle. It will be of
interest to determine which factors, prob-
ably paracrine ones, regulate these early steps
of insulin action in the contralateral kidney
of UNX rats.
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